Skip to main content

Table 1 LPS effects

From: Quantification of [11C]PBR28 data after systemic lipopolysaccharide challenge

ModelParameterLPS Effect
Partial η295% CIOverall (%)MABs (%)HABs (%)
AIF AUCAUC0.87**0.47–0.92− 32.6− 30.0− 38.1
2TCMVT0.87**0.45–0.9246.756.438.9
2TCM-1kVT0.56*0.03–0.7424.310.434.6
MA-1VT0.87**0.46–0.9244.953.337.8
SIMEBPP0.89**0.53–0.9381.994.161.5
SUV, 60–90 minSUV0.350.00–0.61− 9.9− 1.4− 19.8
SUV, 90–120 minSUV0.070.00–0.39− 1.58.7− 13.6
SUVR, 60–90 minSUVR0.340.00–0.61− 3.0− 1.4− 5.5
SUVR, 90–120 minSUVR0.150.00–0.46− 1.3− 0.7− 4.3
  1. LPS effect % = [(Post-LPS − Pre-LPS)/Pre-LPS] × 100. Partial η2 effect size interpretation: “Small” ≤ 0.09, “Moderate” = 0.10–0.24, “Large” ≥ 0.25. 95% CI 95% confidence interval for the partial η2 effect size at p = .05. Significant LPS effects are noted
  2. *p ≤ .05
  3. **p < .01